Fig. 1.
The effect of subcutaneous semaglutide compared to placebo or GLP-1 RA comparator on HbA1c (A) and body weight (B). Data are presented as effect size with 95% CI, P < 0.05
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.